Intragastric alendronate therapy in two infants with vitamin D intoxication: A new method

Clinical Toxicology

Volumn 46, Issue 4, 2008, Pages 300-302

  Doneray, Hakan ^a   Ozkan, Behzat ^a   Caner, Ibrahim ^a   Ozkan, Asuman ^a   Karakelleoglu, Cahit ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Alendronate; Vitamin D intoxication

Indexed keywords

ALENDRONIC ACID; FUROSEMIDE; SODIUM CHLORIDE; VITAMIN D;

ABSENCE OF SIDE EFFECTS; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; DRUG DOSE INCREASE; FEMALE; HUMAN; HYPERCALCEMIA; INFANT; MALE; MUSCLE HYPOTONIA; NASOGASTRIC TUBE; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION;

ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; HYPERCALCEMIA; INFANT; INTUBATION, GASTROINTESTINAL; MALE; NEPHROCALCINOSIS; OVERDOSE; TREATMENT OUTCOME; VITAMIN D;

EID: 41149083507     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701455361     Document Type: Article

References (14)

1. Bereket A, Erdogan T. Oral bisphosphonate therapy for vitamin D intoxication of the infant. Pediatrics 2003; 111:899-901.
2. Kohane D, Tobin J, Kohane I. Endocrine, mineral, and metabolic disease in pediatric intensive care. In: Rogers M.C, Nichols DG, eds. Textbook of Pediatric Intensive Care. Philedelphia: Lippincott Williams & Wilkins, 1996.
3. Lteif AN, Zimmerman D. Bisphosphonates for treatment of childhood hypercalcemia. Pediatrics 1998; 102:990-993.
4. Srivastava T, Alon US. The role of bisphosphonates in diseases of childhood. Eur J Pediatr 2003; 162:735-751.
5. Seikaly MG, Baum M. Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia. Pediatrics 2001; 108:E6.
6. Cesur Y, Caksen H, Gundem A, Kirimi E, Odabas D. Comparison of low and high dose of vitamin D treatment in nutritional vitamin D deficiency rickets. J Pediatr Endocrinol Metab 2003; 16:1105-1109.
7. Greenbaum LA. Electrolyte and Acid-Base Disorders. In: Behrman R.E, Kliegman R.M, Jenson H.B, eds. Nelson Textbook of Pediatrics. Philadelphia: WB Saunders, 2004.
8. Selby PL, Davies M, Marks JS, Mawer EB. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrinol (Oxf) 1995; 43:531-536.
9. Gonzalez-Moles MA, Bagan-Sebastian JV. Alendronate-related oral mucosa ulcerations. J Oral Pathol Med 2000; 29:514-518.
10. Demerjian N, Bolla G, Spreux A. Severe oral ulcerations induced by alendronate. Clin Rheumatol 1999; 18:349-350.
11. Elliott SN, McKnight W, Davies NM, MacNaughton WK, Wallace JL. Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci 1998; 62:77-91.
12. Wilkes-Holmes C. Safe placement of nasogastric tubes in children. Paediatr Nurs 2006; 18:14-17.
13. Atabek ME, Pirgon O, Sert A. Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis. J Pediatr Endocrinol Metab 2006; 19:169-172.
14. Unal E, Abaci A, Bober E, Buyukgebiz A. Efficacy and safety of oral alendronate treatment in children and adolescents with osteoporosis. J Pediatr Endocrinol Metab 2006; 19:523-528.